ALL THE LATEST NEWS ABOUT THE BUSINESS OF PC GAMES

News

Remedy has signed a publishing agreement for two new games

Remedy has signed a publishing agreement for two new games

Finnish game maker Remedy Entertainment has revealed that it has signed with a "major publisher" for two upcoming games.

In a post on its investor portal, the firm said that it is retaining the IP rights to these projects. The publisher is fully funding the game development costs, with Remedy receiving 50 per cent of net revenue from sales.

The first project is a triple-A multi-platform release which is at the pre-production stage already. Remedy has mentioned the title before as "unannounced third project". Meanwhile, the second game is on a smaller scale within the same franchise.

These titles are going to be multi-platform releases, coming to both PC and console.

This news follows a hugely successful year for Remedy. The firm announced that revenue was up 57 per cent year-on-year during 2019 thanks to the success of its latest IP, Control. That title was published by 505 Games, whose parent company Digital Bros was paid $10.5m by Epic Games to release the project on its storefront exclusively on PC.

At Devcom, Remedy CEO Tero Virtala (pictured) said that the budget for Control was between €20m ($22.2m) and €30m ($33.3m). Speaking to PCGamesInsider.biz at Gamescom, the exec said that the studio's strategy involved spending less money on titles to reduce risks

Last year, Remedy bought back the publishing rights to Alan Wake from Microsoft, who released the game originally. 


PCGamesInsider Contributing Editor

Alex Calvin is a freelance journalist who writes about the business of games. He started out at UK trade paper MCV in 2013 and left as deputy editor over three years later. In June 2017, he joined Steel Media as the editor for new site PCGamesInsider.biz. In October 2019 he left this full-time position at the company but still contributes to the site on a daily basis. He has also written for GamesIndustry.biz, VGC, Games London, The Observer/Guardian and Esquire UK.